ArticleAnalytical and bioanalytical chemistry2025
Highly sensitive detection of miRNA based on a quencher-free fluorescence strategy with dual-signal amplification.
Article in Analytical and bioanalytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- An Ultrasensitive Label-Free Aptasensor for Insulin Detection Assisted by Exonuclease III and 2-Aminopurine.Molecules (Basel, Switzerland) · 2026Article
- Sensitive and selective detection of microRNA using hyperbranched rolling circle amplification based on symmetric dumbbell-type probe.Analytical and bioanalytical chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
MicroRNAs (miRNAs) have emerged as crucial post-transcriptional regulators of gene expression and promising biomarkers for disease diagnosis and prognosis. Their aberrant expression levels are closely associated with the pathogenesis and progression of various human diseases. In this study, we developed a novel quencher-free dual-signal amplification strategy for highly sensitive miRNA detection. The approach involves the use of a target-specific padlock probe that undergoes miRNA-triggered circularization to initiate rolling circle amplification (RCA). The resulting RCA products then hybridize with 2-aminopurine-labeled hairpin probes, maintaining fluorescence quenching in the hybridized state. Upon introduction of exonuclease III, the enzyme-mediated cyclic cleavage enables duplex structures to release numerous 2-aminopurine molecules into the solution, generating a strong fluorescence signal through dual amplification (RCA and exonuclease III digestion). This innovative design eliminates the requirement for conventional quencher molecules while achieving high sensitivity, and the method has a detection limit of 63 aM for miRNA-21 and possesses single-base mismatch discrimination capability. The clinical applicability of the method was demonstrated through direct quantification of miRNA-21 in both human serum samples and tumor cell lysates without the need for total RNA extraction. These results validate the potential of the strategy for early cancer diagnosis.
Indexed as
Identifiers
41047399What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.